Pharming Group N.V. - ADR

NASDAQ:PHAR 12:42:33 PM EDT

12.12

-0.03 (-0.25%)

Market Cap (Intraday)	773.30M
Current PE	24.43
Forward PE	12.12
2yr Forward PE	10.36

See more stats

Estimates Current Quarter

Revenue	$68.15 Million
Adjusted EPS	$0.17

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Pharming Group N.V. - ADR Stock, NASDAQ:PHAR

Darwinweg 24, Leiden, Zuid-Holland 2332 CR

Netherlands

Phone: +31.71.524.74.00

Number of Employees:

http://www.pharming.com

Description

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The company offers RUCONEST which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following geographical segments: the United States, Europe, and Rest of the World. The company was founded on November 11, 1988 and is headquartered in Leiden, the Netherlands.